DD291779A5 - Verfahren zur herstellung eines gewebs-plasminogenaktivator-derivats - Google Patents

Verfahren zur herstellung eines gewebs-plasminogenaktivator-derivats Download PDF

Info

Publication number
DD291779A5
DD291779A5 DD90337557A DD33755790A DD291779A5 DD 291779 A5 DD291779 A5 DD 291779A5 DD 90337557 A DD90337557 A DD 90337557A DD 33755790 A DD33755790 A DD 33755790A DD 291779 A5 DD291779 A5 DD 291779A5
Authority
DD
German Democratic Republic
Prior art keywords
derivative
actilyse
plasmid
arginine
protein
Prior art date
Application number
DD90337557A
Other languages
German (de)
English (en)
Inventor
Anne Stern
Ulrich Kohnert
Rainer Rudolph
Stephan Fischer
Ulrich Martin
Original Assignee
��@���������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��@���������@�������k�� filed Critical ��@���������@�������k��
Publication of DD291779A5 publication Critical patent/DD291779A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Detergent Compositions (AREA)
DD90337557A 1989-02-07 1990-02-02 Verfahren zur herstellung eines gewebs-plasminogenaktivator-derivats DD291779A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3903581A DE3903581A1 (de) 1989-02-07 1989-02-07 Gewebs-plasminogenaktivator-derivat

Publications (1)

Publication Number Publication Date
DD291779A5 true DD291779A5 (de) 1991-07-11

Family

ID=6373566

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90337557A DD291779A5 (de) 1989-02-07 1990-02-02 Verfahren zur herstellung eines gewebs-plasminogenaktivator-derivats

Country Status (29)

Country Link
US (1) US5223256A (el)
EP (1) EP0382174B1 (el)
JP (1) JP2559538B2 (el)
KR (1) KR970008485B1 (el)
AT (1) ATE126270T1 (el)
AU (1) AU623228B2 (el)
CA (1) CA2025900C (el)
CZ (1) CZ281836B6 (el)
DD (1) DD291779A5 (el)
DE (2) DE3903581A1 (el)
DK (1) DK0382174T3 (el)
ES (1) ES2031804T3 (el)
FI (1) FI100244B (el)
GR (2) GR900300140T1 (el)
HK (1) HK153396A (el)
HU (1) HU218092B (el)
IE (1) IE61077B1 (el)
IL (1) IL93280A (el)
LU (1) LU90025I2 (el)
LV (1) LV10302B (el)
NL (1) NL970008I2 (el)
NO (2) NO306563B1 (el)
NZ (1) NZ232337A (el)
PT (1) PT93082B (el)
RU (1) RU2107094C1 (el)
SK (1) SK279029B6 (el)
UA (1) UA27111A1 (el)
WO (1) WO1990009437A1 (el)
ZA (1) ZA90861B (el)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634007A (en) * 1985-12-02 1987-01-06 Adolph Coors Company Carton blank with perforated tear line

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5676947A (en) * 1989-02-07 1997-10-14 Boehringer Manneheim Gmbh Method for treating thromboembolic conditions using thrombolytically active proteins
DE3923339A1 (de) * 1989-05-31 1990-12-06 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator-derivat
GB9019120D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds
DE4037196A1 (de) * 1990-11-22 1992-05-27 Boehringer Mannheim Gmbh Verfahren zur reaktivierung von denaturiertem protein
DK0580685T3 (da) * 1991-04-16 1996-03-04 Boehringer Mannheim Gmbh Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift
DE4123845A1 (de) * 1991-07-18 1993-01-21 Boehringer Mannheim Gmbh Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
DE4423574A1 (de) * 1994-07-05 1996-01-11 Boehringer Mannheim Gmbh Nicht-glykosylierte Plasminogenaktivator-Derivate und ihre Verwendung bei erhöhtem Blutungsrisiko
US5723122A (en) * 1995-06-01 1998-03-03 Boehringer Mannheim Gmbh Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
WO1996017928A1 (en) * 1994-12-06 1996-06-13 Boehringer Mannheim Gmbh Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
WO1997038123A1 (en) * 1996-04-05 1997-10-16 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
ES2255177T5 (es) * 1997-07-23 2011-07-12 Roche Diagnostics Gmbh Fabricación de proteínas mutadas humanas en células humanas por medio de la recombinación homóloga.
WO1999009185A1 (de) * 1997-08-13 1999-02-25 Roche Diagnostics Gmbh Plasminogenaktivator mit verbesserter zymogenität
WO1999009184A1 (de) * 1997-08-13 1999-02-25 Roche Diagnostics Gmbh Plasminogenaktivator mit verbesserter zymogenität und verminderter fibrinbindung
DE10105912A1 (de) * 2001-02-09 2002-08-14 Roche Diagnostics Gmbh Rekombinante Proteinase K
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
TWI482628B (zh) * 2007-10-18 2015-05-01 Lundbeck & Co As H 新穎之血栓溶解病患次群
EP2289542A1 (en) 2009-08-31 2011-03-02 PAION Deutschland GmbH Treatment of neurological or neurodegenerative disorders
EP2289541A1 (en) 2009-08-31 2011-03-02 PAION Deutschland GmbH Treatment of neurological or neurodegenerative disorders
MX2019009137A (es) 2017-02-03 2019-12-19 Acticor Biotech Inhibicion de agregacion plaquetaria usando anticuerpos gpvi antihumanos.
WO2018210860A1 (en) 2017-05-16 2018-11-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of acute ischemic stroke
US20210238605A1 (en) 2018-06-15 2021-08-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of pi3kc2b inhibitors for the preservation of vascular endothelial cell barrier integrity
WO2021148439A1 (en) 2020-01-21 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for stimulating cerebrovascular function
WO2021249974A1 (en) 2020-06-09 2021-12-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Fucoidan-functionalized polysaccharide particles with t-pa for targeted thrombolytic therapy
WO2023156683A1 (en) 2022-02-21 2023-08-24 Acticor Biotech Treatment of cardiovascular diseases using anti-human gpvi antibodies

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
US5073494A (en) * 1985-04-22 1991-12-17 Genentech, Inc. Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
DE3611817A1 (de) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh Verfahren zur renaturierung von proteinen
DE3643158A1 (de) * 1986-04-21 1987-11-19 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator(tpa) - derivat und seine herstellung
JPH0779692B2 (ja) * 1986-05-07 1995-08-30 三井東圧化学株式会社 一本鎖ｔ−ＰＡと二本鎖ｔ−ＰＡを分離する方法
US4898825A (en) * 1986-05-07 1990-02-06 Mitsui Toatsu Chemicals, Incorporated Methods for purification of single-chain and double-chain tissue plasminogen activator
JPS6463378A (en) * 1986-08-11 1989-03-09 Mitsui Toatsu Chemicals Separation of single stranded tpa and double standard tpa
SE8702562L (sv) * 1987-06-18 1988-12-19 Kabigen Ab Nya fibrinolytiska enzymer
US4935237A (en) * 1988-03-21 1990-06-19 Genentech, Inc. Processes for the preparation of t-PA mutants
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
US5037752A (en) * 1987-10-09 1991-08-06 Monsanto Company Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277
US4963357A (en) * 1987-10-09 1990-10-16 Monsanto Company Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634007A (en) * 1985-12-02 1987-01-06 Adolph Coors Company Carton blank with perforated tear line

Also Published As

Publication number Publication date
KR970008485B1 (ko) 1997-05-24
IE61077B1 (en) 1994-09-21
HUT58813A (en) 1992-03-30
HK153396A (en) 1996-08-16
NL970008I2 (nl) 1997-07-01
IE900343L (en) 1990-08-07
SK55890A3 (en) 1998-05-06
CA2025900C (en) 1999-01-19
LV10302A (lv) 1994-10-20
RU2107094C1 (ru) 1998-03-20
ATE126270T1 (de) 1995-08-15
EP0382174B1 (de) 1995-08-09
NO2000002I1 (no) 2000-05-19
EP0382174A1 (de) 1990-08-16
PT93082B (pt) 1996-03-29
FI100244B (fi) 1997-10-31
PT93082A (pt) 1990-08-31
DE3903581A1 (de) 1990-08-16
NZ232337A (en) 1991-09-25
IL93280A (en) 1995-08-31
LV10302B (en) 1995-04-20
CA2025900A1 (en) 1990-08-08
AU5047090A (en) 1990-09-05
LU90025I2 (fr) 1997-04-22
ES2031804T1 (es) 1993-01-01
HU218092B (hu) 2000-05-28
NO904211D0 (no) 1990-09-27
NL970008I1 (nl) 1997-04-01
KR910700336A (ko) 1991-03-14
HU901644D0 (en) 1991-04-29
JPH03500724A (ja) 1991-02-21
CZ281836B6 (cs) 1997-02-12
DK0382174T3 (da) 1996-01-02
UA27111A1 (uk) 2000-02-28
GR3017099T3 (en) 1995-11-30
US5223256A (en) 1993-06-29
ES2031804T3 (es) 1995-11-01
AU623228B2 (en) 1992-05-07
JP2559538B2 (ja) 1996-12-04
NO306563B1 (no) 1999-11-22
IL93280A0 (en) 1990-11-29
DE59009487D1 (de) 1995-09-14
SK279029B6 (sk) 1998-05-06
WO1990009437A1 (de) 1990-08-23
NO904211L (no) 1990-09-27
FI904951A0 (fi) 1990-10-08
GR900300140T1 (en) 1991-09-27
ZA90861B (en) 1990-11-28
CZ55890A3 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
EP0382174B1 (de) Gewebs-Plasminogenaktivator-Derivat
AT391812B (de) Verfahren zur herstellung einer parenteralen t-pa-loesung
DE69433133T2 (de) Lösliches thrombomodulin enthaltende zubereitung
DE3708681C2 (de) Human-Gewebeplasminogen-Aktivator, Verfahren zu seiner Herstellung und seine Verwendung als Arzneistoff
DE4411143C2 (de) Thrombosemittel
DD251791A5 (de) Verfahren zur Herstellung von protease-resistenter Urokrinase
DE69333491T2 (de) Protease-Resistant Thrombomodulin Analogs
EP0669394B1 (de) Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
EP0361475A1 (de) Präparat von in Prokaryonten exprimiertem Plasminogenaktivator
DE4423574A1 (de) Nicht-glykosylierte Plasminogenaktivator-Derivate und ihre Verwendung bei erhöhtem Blutungsrisiko
EP0714982A2 (de) Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
EP0400545B1 (de) Gewebs-Plasminogen-Aktivator-Derivat
DE4440892A1 (de) Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
EP0917567A1 (de) Thrombinaktivierbarer plasminogenaktivator
WO1999009184A1 (de) Plasminogenaktivator mit verbesserter zymogenität und verminderter fibrinbindung
DE4443273A1 (de) Verwendung der Proteasedomäne von humanem Plasminogenaktivator zur Behandlung von thromboembolischen Erkrankungen
DD299155A5 (de) Pharmazeutische zubereitungen
WO1999009185A1 (de) Plasminogenaktivator mit verbesserter zymogenität

Legal Events

Date Code Title Description
RPI Change in the person, name or address of the patentee (searches according to art. 11 and 12 extension act)
ENJ Ceased due to non-payment of renewal fee